{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:11:21Z","timestamp":1789445481651,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T00:00:00Z","timestamp":1345680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00418-012-1019-z","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T02:15:41Z","timestamp":1345601741000},"page":"381-389","source":"Crossref","is-referenced-by-count":31,"title":["Expression of vascular endothelial growth factor C in human pterygium"],"prefix":"10.1007","volume":"139","author":[{"given":"Junichi","family":"Fukuhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ohguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,23]]},"reference":[{"key":"1019_CR1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen MG, Jeltsch M, Kukk E, M\u00e4kinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548\u2013553","journal-title":"Proc Natl Acad Sci USA"},{"key":"1019_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/modpathol.3800985","volume":"21","author":"S Aishima","year":"2008","unstructured":"Aishima S, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M (2008) Lymphatic spread is related to VEGF-C expression and D2\u201340-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol 21:256\u2013264","journal-title":"Mod Pathol"},{"key":"1019_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00418-010-0751-5","volume":"134","author":"H Bai","year":"2010","unstructured":"Bai H, Teng Y, Wong L, Jhanji V, Pang CP, Yam GH (2010) Proliferative and migratory aptitude in pterygium. Histochem Cell Biol 134:527\u2013535","journal-title":"Histochem Cell Biol"},{"key":"1019_CR4","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1158\/0008-5472.CAN-05-0885","volume":"65","author":"Z Chen","year":"2005","unstructured":"Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, Singh RK (2005) Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 65:9004\u20139011","journal-title":"Cancer Res"},{"key":"1019_CR5","first-page":"635","volume":"13","author":"CC Chiang","year":"2007","unstructured":"Chiang CC, Cheng YW, Lin CL, Lee H, Tsai FJ, Tseng SH, Tsai YY (2007) Cyclooxygenase 2 expression in pterygium. Mol Vis 13:635\u2013638","journal-title":"Mol Vis"},{"key":"1019_CR6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajpath.2010.10.037","volume":"178","author":"J Chui","year":"2011","unstructured":"Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N (2011) Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 178:817\u2013827","journal-title":"Am J Pathol"},{"key":"1019_CR7","unstructured":"Cimpean AM, Poenaru Sava M, Raica M, Ribatti D (2011) Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium. Oncol Rep 26:1111\u20131113"},{"key":"1019_CR8","first-page":"2127","volume":"43","author":"C Cursiefen","year":"2002","unstructured":"Cursiefen C, Schl\u00f6tzer-Schrehardt U, K\u00fcchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 43:2127\u20132135","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1019_CR9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/ICO.0b013e31821c9b44","volume":"30","author":"O Enkvetchakul","year":"2011","unstructured":"Enkvetchakul O, Thanathanee O, Rangsin R, Lekhanont K, Suwan-Apichon O (2011) A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results. Cornea 30:1213\u20131218","journal-title":"Cornea"},{"key":"1019_CR10","doi-asserted-by":"crossref","unstructured":"Feng Y, Hu J, Ma\u00a0J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y (2011) RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Eur J Cancer 47:2353\u20132363","DOI":"10.1016\/j.ejca.2011.05.006"},{"key":"1019_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","volume":"112","author":"M Gebhardt","year":"2005","unstructured":"Gebhardt M, Mentlein R, Schaudig U, Pufe T, Recker K, N\u00f6lle B, Al-Samir K, Geerling G, Paulsen FP (2005) Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmology 112:1023\u20131030","journal-title":"Ophthalmology"},{"key":"1019_CR12","first-page":"3127","volume":"27","author":"E Herrmann","year":"2007","unstructured":"Herrmann E, Eltze E, Bierer S, K\u00f6pke T, G\u00f6rge T, Neumann J, Hertle L, W\u00fclfing C (2007) VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival. Anticancer Res 27:3127\u20133133","journal-title":"Anticancer Res"},{"key":"1019_CR13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000101855","volume":"39","author":"WG Hu","year":"2007","unstructured":"Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH (2007) Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Eur Surg Res 39:229\u2013238","journal-title":"Eur Surg Res"},{"key":"1019_CR14","doi-asserted-by":"crossref","first-page":"10181","DOI":"10.1158\/0008-5472.CAN-07-2366","volume":"67","author":"C Iwata","year":"2007","unstructured":"Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, Miyazono K (2007) Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67:10181\u201310189","journal-title":"Cancer Res"},{"key":"1019_CR15","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/j.1460-2075.1996.tb00521.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751","journal-title":"EMBO J"},{"key":"1019_CR16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.2004.00.3467","volume":"24","author":"S J\u00fcttner","year":"2006","unstructured":"J\u00fcttner S, Wissmann C, J\u00f6ns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, H\u00f6cker M (2006) Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24:228\u2013240","journal-title":"J Clin Oncol"},{"key":"1019_CR17","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566\u20133570","journal-title":"Proc Natl Acad Sci USA"},{"key":"1019_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74\u201380","journal-title":"Nat Immunol"},{"key":"1019_CR19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bjo.2007.115709","volume":"91","author":"S Kase","year":"2007","unstructured":"Kase S, Osaki M, Sato I, Takahashi S, Nakanishi K, Yoshida K, Ito H, Ohno S (2007a) Immunolocalisation of E-cadherin and beta-catenin in human pterygium. Br J Ophthalmol 91:1209\u20131212","journal-title":"Br J Ophthalmol"},{"key":"1019_CR20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bjo.2006.110387","volume":"91","author":"S Kase","year":"2007","unstructured":"Kase S, Takahashi S, Sato I, Nakanishi K, Yoshida K, Ohno S (2007b) Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 91:958\u2013961","journal-title":"Br J Ophthalmol"},{"key":"1019_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2011.03.008","volume":"55","author":"P Liu","year":"2011","unstructured":"Liu P, Zhou J, Zhu H, Xie L, Wang F, Liu B, Shen W, Ye W, Xiang B, Zhu X, Shi R, Zhang S (2011) VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression. Cytokine 55:8\u201317","journal-title":"Cytokine"},{"key":"1019_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-5347(06)00520-9","volume":"176","author":"Y Miyata","year":"2006","unstructured":"Miyata Y, Kanda S, Ohba K, Nomata K, Eguchi J, Hayashida Y, Kanetake H (2006) Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 176:348\u2013353","journal-title":"J Urol"},{"key":"1019_CR23","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)65021-3","volume":"156","author":"K Paavonen","year":"2000","unstructured":"Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156:1499\u20131504","journal-title":"Am J Pathol"},{"key":"1019_CR24","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1158\/1535-7163.MCT-08-0182","volume":"7","author":"TP Padera","year":"2008","unstructured":"Padera TP, Kuo AH, Hoshida T, Liao S, Lobo J, Kozak KR, Fukumura D, Jain RK (2008) Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. Mol Cancer Ther 7:2272\u20132279","journal-title":"Mol Cancer Ther"},{"key":"1019_CR25","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1096\/fj.99-1049com","volume":"14","author":"TA Partanen","year":"2000","unstructured":"Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14:2087\u20132096","journal-title":"FASEB J"},{"key":"1019_CR26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192\u2013198","journal-title":"Nat Med"},{"key":"1019_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bjo.81.6.493","volume":"81","author":"DA Spandidos","year":"1997","unstructured":"Spandidos DA, Sourvinos G, Kiaris H, Tsamparlakis J (1997) Microsatellite instability and loss of heterozygosity in human pterygia. Br J Ophthalmol 81:493\u2013496","journal-title":"Br J Ophthalmol"},{"key":"1019_CR28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1464-410X.2006.06403.x","volume":"98","author":"L Trojan","year":"2006","unstructured":"Trojan L, Rensch F, Voss M, Grobholz R, Weiss C, Jackson DG, Alken P, Michel MS (2006) The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int 98:903\u2013906","journal-title":"BJU Int"},{"key":"1019_CR29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.969","volume":"195","author":"AN Witmer","year":"2001","unstructured":"Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, Schlingemann RO (2001) VEGFR-3 in adult angiogenesis. J Pathol 195:490\u2013497","journal-title":"J Pathol"},{"key":"1019_CR30","doi-asserted-by":"crossref","unstructured":"Yuen D, Pytowski B, Chen L (2011) Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages. Invest Ophthalmol Vis Sci 52:2593\u20132597","DOI":"10.1167\/iovs.10-6408"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-012-1019-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00418-012-1019-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-012-1019-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T01:23:08Z","timestamp":1562116988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00418-012-1019-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,23]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1007\/s00418-012-1019-z","relation":{},"ISSN":["0948-6143","1432-119X"],"issn-type":[{"value":"0948-6143","type":"print"},{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,23]]}}}